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Skin Prick Test 
Exclusion & Inclusion Criteria 
The inclusion criteria was such that only double-blind randomized 
controlled clinical trial (RCT) were used. The intervention had to be 
supplementation with DHA/EPA and the clinical outcome had to 
involve skin prick test (SPT) analysis and clinical diagnosis of eczema 
to determine atopy. Exclusion criteria were studies that involved 
continuing supplementing post partum
Hypothesis
High levels of prenatal n-3 PUFA will have an immunological effect on 
the offspring by decreasing allergic risk later in life 
Introduction
The prevalence of allergic diseases has increased immensely over the 
past 2-3 decades, leading to significant decrease in the quality of life in 
patients who suffer from such disease states. The proposal of certain 
dietary changes during gestation to enhance the immune system in utero 
has been brought to light, specifically in the form of omega-3 
polyunsaturated fatty acid (n-3 PUFA). This meta-analysis poses to 
provide a conclusion to if high levels of prenatal n-3 PUFA will have an 
immunological effect on the fetus thus decreasing their allergic risk later 
in life
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Figure 2: Shows a simple 
procedure and positive result 
of skin prick testing that was 
used to determine allergic 
risk in the studies used in 
this meta-analysis  
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Figure 4: Dosages per study correlating with number 
of statistically significant results observed  per study
Conclusion
• There is conflicting evidence supporting 
high levels of fish oil in pregnancy and 
the allergic risk of the offspring
• Dosages of 900 mg of n-3 PUFA 
correspond to the most positive results in 
regards to SPT and eczema rates over 
higher doses
• There has been no negative results 
reported for prenatal n-3 supplementation 
and can pose as an additional benefit to 
the fetus 
Future Research
• More RCT studies involving long-term 
follow up is needed to determine 
benefit. 
• Studies observing similar characteristics 
(SPT, eczema diagnosis) are needed 
with differing doses to determine the 
most efficient dose needed to provide 
benefit
• Determining at what point during 
gestation is most critical to begin 
supplementation  
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N-3 vs N-6
The theory behind looking at n-3 PUFA specifically during gestation 
is due to the concept that diet is a driving force behind this allergic 
trend. The ratio of polyunsaturated fatty acids omega-6 (n-6) and 
omega-3 (n-3) in modern diets is imbalanced favoring n-6. Vegetable 
oils (sunflower, corn, soybean), which are used vastly in processed 
and fast foods are sources of n-6 PUFA. N-3 PUFA is mostly found 
in fish (salmon, mackerel, tuna) and seeds. On a molecular level 
these two compete for which specific molecules are incorporated into 
the cell membrane. In those with a n-6 PUFA predominance, 
Arachodnic acid is more favorably incorporated into the cells, which 
is a highly inflammatory substrate. Whereas, a diet that is high in n-3 
PUFA will have a predominance of D.ocosahexenoic acid (DHA) and 
Eicosapentenoic aicd (EPA) which works to counteract the 
inflammatory response of Arachdonic acid as well as decrease 
cytokine and immunoglobulin E (IgE) production which are main 
contributors to the allergic cascade.
Figure 1: Depicts the modern diet and how a pro-
inflammatory state is favored over an anti-inflammatory 
diet 
Figure 3 : Data from 6 RCT, in regards to SPT results from egg 
and dust mites and clinical diagnosis of eczema by a medical 
professional      
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Adverse Outcomes
Of all the studies there were no adverse outcomes in regards to age at delivery, birth 
weight, mode of delivery and Apgar scores 
